Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Zheyu Wang, Fujun Wang, Chenguang Wang, Jianliang Zhang, Hao Wang, Li Shi, Zhuojun Tang & Gary L. Rosner. (2022) A Bayesian Decision-Theoretic Design for Simultaneous Biomarker-Based Subgroup Selection and Efficacy Evaluation. Statistics in Biopharmaceutical Research 14:4, pages 568-579.
Read now
Read now
Ryuji Uozumi & Chikuma Hamada. (2020) Utility-Based Interim Decision Rule Planning in Adaptive Population Selection Designs With Survival Endpoints. Statistics in Biopharmaceutical Research 12:3, pages 360-368.
Read now
Read now
Laura Benner & Meinhard Kieser. (2018) Timing of the interim analysis in adaptive enrichment designs. Journal of Biopharmaceutical Statistics 28:4, pages 622-632.
Read now
Read now
Johannes Krisam & Meinhard Kieser. (2017) Optimal Interim Decision Rules Based on a Binary Surrogate Outcome for Adaptive Biomarker-Based Trials in Oncology. Statistics in Biopharmaceutical Research 9:4, pages 321-332.
Read now
Read now
Thomas Ondra, Alex Dmitrienko, Tim Friede, Alexandra Graf, Frank Miller, Nigel Stallard & Martin Posch. (2016) Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review. Journal of Biopharmaceutical Statistics 26:1, pages 99-119.
Read now
Read now
Heiko Götte, Margarita Donica & Giacomo Mordenti. (2015) Improving Probabilities of Correct Interim Decision in Population Enrichment Designs. Journal of Biopharmaceutical Statistics 25:5, pages 1020-1038.
Read now
Read now
Tony Sabin, James Matcham, Andrew Copas & Mahesh K. B. Parmar. (2015) Assessing End of Phase 2 Decision Criteria. Statistics in Biopharmaceutical Research 7:3, pages 230-237.
Read now
Read now
Articles from other publishers (14)
Beibo Zhao, Anastasia Ivanova & Jason Fine. (2023) Inference on subgroups identified based on a heterogeneous treatment effect in a post hoc analysis of a clinical trial. Clinical Trials 20:4, pages 370-379.
Crossref
Crossref
Yong Lin, Weichung J. Shih & Shou‐En Lu. (2019) Two‐stage enrichment clinical trial design with adjustment for misclassification in predictive biomarkers. Statistics in Medicine 38:29, pages 5445-5469.
Crossref
Crossref
Thomas Ondra, Sebastian Jobjörnsson, Robert A Beckman, Carl-Fredrik Burman, Franz König, Nigel Stallard & Martin Posch. (2017) Optimized adaptive enrichment designs. Statistical Methods in Medical Research 28:7, pages 2096-2111.
Crossref
Crossref
Toshifumi Sugitani, Martin Posch, Frank Bretz & Franz Koenig. (2018) Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup. Statistics in Medicine 37:24, pages 3387-3402.
Crossref
Crossref
Shu-Chih Su, Xiaoming Li, Yanli Zhao & Ivan S. F. Chan. (2017) Population-Enrichment Adaptive Design Strategy for an Event-Driven Vaccine Efficacy Trial. Statistics in Biosciences 10:2, pages 357-370.
Crossref
Crossref
Prema Nedungadi, Akshay Iyer, Georg Gutjahr, Jasmine Bhaskar & Asha B. Pillai. (2018) Data-Driven Methods for Advancing Precision Oncology. Current Pharmacology Reports 4:2, pages 145-156.
Crossref
Crossref
Kevin Kunzmann, Laura Benner & Meinhard Kieser. (2017) Point estimation in adaptive enrichment designs. Statistics in Medicine 36:25, pages 3935-3947.
Crossref
Crossref
Julien Tanniou, Ingeborg van der Tweel, Steven Teerenstra & Kit C. B. Roes. (2016) Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes. BMC Medical Research Methodology 16:1.
Crossref
Crossref
Thomas Ondra, Sebastian Jobjörnsson, Robert A. Beckman, Carl-Fredrik Burman, Franz König, Nigel Stallard & Martin Posch. (2016) Optimizing Trial Designs for Targeted Therapies. PLOS ONE 11:9, pages e0163726.
Crossref
Crossref
Shoichi Ohwada & Satoshi Morita. (2016) Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial. Pharmaceutical Statistics 15:5, pages 420-429.
Crossref
Crossref
Johannes Krisam & Meinhard Kieser. (2015) Performance of Biomarker-Based Subgroup Selection Rules in Adaptive Enrichment Designs. Statistics in Biosciences 8:1, pages 8-27.
Crossref
Crossref
Gernot Wassmer & Werner BrannathGernot Wassmer & Werner Brannath. 2016. Group Sequential and Confirmatory Adaptive Designs in Clinical Trials. Group Sequential and Confirmatory Adaptive Designs in Clinical Trials
241
276
.
Ekkehard Glimm & Lilla Di Scala. (2015) An approach to confirmatory testing of subpopulations in clinical trials. Biometrical Journal 57:5, pages 897-913.
Crossref
Crossref
Johannes Krisam & Meinhard Kieser. (2015) Optimal Decision Rules for Biomarker-Based Subgroup Selection for a Targeted Therapy in Oncology. International Journal of Molecular Sciences 16:12, pages 10354-10375.
Crossref
Crossref